SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Elon Musks warning that neocloud providers face failures and consolidation, alongside concerns about tightening debt markets, is weighing on CoreWeave amid existing worries about its leveraged data-center expansion and financing costs. Traders debate whether Musk is attacking a competitor or flagging genuine risks, while some dip buyers argue AI demand and Nvidias backing support the company.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

Elon Musks warning that neoclouds could face failures and consolidation, alongside SpaceXs stated lack of interest in acquiring one, has sharpened attention on IREN amid wider concerns about debt-funded data-center expansion and tighter credit. Traders are divided between viewing the comments as competitive FUD and emphasizing IRENs contracts and infrastructure, and fearing further sector-wide selling and execution or financing risks.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Elon Musks warning that neoclouds could face failures and consolidation, alongside concerns about tightening financing for AI infrastructure, has fueled discussion of the sectors selloff. Traders debate whether Nebius is being unfairly grouped with more leveraged peers, pointing to its financing and customer demand, while skeptics focus on debt, capital spending and execution risks.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas Phase 3 melanoma vaccine results with Mercks Keytruda, showing a 42% reduction in recurrence or death risk, are driving discussion alongside a sharp selloff after the data failed to exceed some investors expectations. Bulls view the results and other cancer-program updates as validation of a broader oncology platform, while bears question how much success is already priced in and whether the personalized treatment can become commercially viable.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

CIFR is caught in a sharp selloff as traders debate concerns about AI data-center financing after Elon Musk warned that tighter debt markets could pressure compute companies, alongside worries about Ciphers convertible-note offering and related dilution or hedging. Bulls argue its powered-shell, long-term lease model differs from GPU-owning neoclouds and cite its contracted HPC business, while bears focus on financing, execution and weak sector sentiment.

iShares Inc. - iShares MSCI Brazil ETF

iShares MSCI Brazil ETF

Brazilian equities are selling off after Lula da Silvas unexpected election victory, renewing trader concerns about political uncertainty and the outlook for Brazils economy. The community is divided between bearish reactions and claims the selloff is an overreaction or a buying opportunity; allegations that the vote was rigged remain speculation.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Traders are focused on SELLASs REGAL Phase 3 trial of GPS in AML, particularly the long-awaited 80th overall-survival event and final data; speculation centers on when results may emerge and whether they will be presented at ASH. Some interpret the slow event accumulation as a possible sign of longer survival, while skeptics see the prolonged silence as a reason for concern; SLS009 data is a secondary catalyst.

Lufax Holding Ltd. operates a technology-empowered personal financial services platform. It offers personal lending and wealth management solutions. The company was founded in August 2005 and is headquartered in Shanghai, China.

Lufax Holding Ltd - ADR

Lufaxs warning of a substantial third-quarter loss, attributed to higher credit impairments and tax charges, is weighing on sentiment as traders also react to the reverse stock split and await results. Some view much of the loss as one-time or noncash accounting cleanup, while others worry it signals worsening credit quality and business prospects.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MercadoLibres post-earnings selloff is drawing attention despite a revenue and EPS beat, as investors focus on weaker profitability and margin pressure from heavy investment in shipping, logistics, and credit. Traders are split between concern that margins may stay compressed and confidence that the spending supports continued growth across its Latin American commerce and fintech businesses.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Positive miv-cel results in stiff-person syndrome, alongside durable follow-up in generalized myasthenia gravis, are the main focus as Kyverna advances toward an FDA filing. Traders are weighing the efficacy data and potential first-in-class opportunity against a sell-the-news share-price drop, small study sizes, safety questions and speculation about future dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?

Key PointsCanopy Growth maintains a strategic focus on premium cannabis products and European medical distribution...

Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsCanopy Growth is refining its focus on medical and adult-use markets while managing its U.S. expansion strategy through Canopy USA...

CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?

Cronos Group stock climbs 17% in three months on strong revenue growth and margin gains, but rising competition and regulatory risks raise questions about its upside.

Tilray Brands Q1 2027 Earnings Call Transcript

Tilray Brands (NASDAQ:TLRY) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below.
Benzinga APIs provide real-time access toread more...

Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Misses Revenue Estimates

Tilray Brands (TLRY) delivered earnings and revenue surprises of -68.42% and -1.98%, respectively, for the quarter ended August 2026. Do the numbers hold clues to what lies ahead for the stock?

PepsiCo Could Swing $6.46 Billion In Value After Earnings

Earnings season is set to bring heightened volatility, with PepsiCo, Constellation Brands, Delta Air Lines, Applied Digital and Tilray Brands facing potentially sharp post-earnings moves as options markets price in reactions ranging from 3.76% to 12.24%.read more...

VFF Stock Up 49% in Three Months: Is the Rally Sustainable?

Village Farms' 49% three-month surge is fueled by stronger European cannabis demand and rising profitability, but margin normalization and competition loom.

Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors

The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $4.02, representing a -2.66% change from its previous close.

Should You Buy Tilray Brands Stock Before Oct. 8?

Key PointsTilray's earnings have been volatile in the past due to acquisitions and impairment charges...

Tilray Brands, Inc. (TLRY) Laps the Stock Market: Here's Why

Tilray Brands, Inc. (TLRY) concluded the recent trading session at $4.08, signifying a +2.26% move from its prior day's close.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

PSKY, ORCL, TLRY Stocks Hit 52-Week Lows Today: What's Driving The Selloff? 

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>Paramount stock fell to a 17-year low of $8.56 after a federal judge temporarily blocked its proposed $110 billion acquisition of Warner Bros. Discovery.&nbsp;</li><li>Oracle shares fell as investors worried about heavy AI infrastructure spending and project delays.&nbsp;</li><li>Tilray Brands shares dropped to a 52-week low of $4.19 as investors awaited its July 28 earnings report.</li></ul>Paramount Skydance Corp. (PSKY), Oracle Corp. (ORCL) and Tilray Brands (TLRY) each touched new 52-week lows on Monday as investors weighed merger uncertainty, artificial intelligence spending concerns and ongoing profitability challenges across three different sectors.&nbsp;Paramount Skydance and Oracle stocks dropped 2% and nearly 4%, respectively, while Tilray Brands slipped over 1%.&nbsp;<h2 class="st-heading-2">Federal Judge Puts Paramount-Warner Bros. Deal On Hold&nbsp;</h2><a href="https://stocktwits.com/symbol/PSKY">Paramount Skydance stock</a> plunged to nearly a seventeen-year low of $8.56 on Monday after legal uncertainty surrounding its $110 billion proposed acquisition of Warner Bros. Discovery (WBD) intensified.&nbsp;A federal judge&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/psky-stock-at-record-lows-federal-judge-halts-110-b-paramount-warner-bros-merger/cZZiOZVR7H2">issued</a> a temporary restraining order (TRO) that pauses the proposed combination for at least two weeks while additional legal proceedings are scheduled. The action follows an antitrust challenge backed by a coalition of state attorneys general.Judge Araceli Martínez-Olguín temporarily paused the merger after finding that the states had raised strong enough concerns that it could reduce competition. According to the court, the combined company would control about 27% of the U.S. wide-release movie market and more than 30% of major theatrical film releases. The judge noted that a market share of 30% or more can indicate a possible antitrust issue.On Stocktwits, retail sentiment around the stock improved to ‘extremely bullish’ from ‘bullish’ territory the previous day.&nbsp;<h2 class="st-heading-2">AI Spending Concerns Weigh On Oracle&nbsp;</h2><a href="https://stocktwits.com/symbol/ORCL">Oracle stock</a> reached an annual low of $120.03 due to investor concerns over the company's aggressive artificial intelligence infrastructure investments. Oracle’s planned capital expenditures, together with credit-rating pressure and customer concentration risks, have raised questions about the company's balance sheet.On Monday, CLSA analyst Bhavtosh Vajpayee started coverage of Oracle with a ‘Hold’ rating and a $145 price target. The analyst said enterprise software companies have strong competitive advantages, and believes the sector can recover over time despite its current weakness. However, the firm said software companies need to become more efficient first.Oracle also faced pressure after New Mexico&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/orcl-be-stock-drops-oracle-project-jupiter-pipeline-rejection-new-mexico/cZZieMLR7uM">rejected</a> a permit request for a natural gas pipeline needed to supply power to its Project Jupiter data center. Retail sentiment around the stock remained in ‘extremely bullish’ territory.&nbsp;<h2 class="st-heading-2">Profit Concerns Pressure Tilray&nbsp;</h2><a href="https://stocktwits.com/symbol/TLRY">Tilray Brands stock</a> fell to a new 52-week low of $4.19 as investors grew concerned about the company’s profitability ahead of its July 28 earnings report.Investors are looking for signs that Tilray’s expansion into craft beverages and cannabis can improve its financial performance. Despite the company building new brands and expanding operations, investors remain focused on whether it can reduce losses and generate steady cash flow.Analysts see second-quarter revenue of $249.6 million with&nbsp;breakeven earnings, according to Fiscal AI data. Retail sentiment around the stock remained in ‘bearish’ territory.&nbsp;So far this year, PSKY, ORCL and TLRY stocks have crashed between 36% and 53%.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-signs-orders-on-aluminum-and-defense-supply-chains-aa-kalu-cenx-mp-stocks-in-focus/cZZikEER7H9">Trump Signs Orders On Aluminum And Defense Supply Chains — AA, KALU, CENX, MP Stocks In Focus</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Paramount Global logo is seen on a smartphone and Skydance Media logo in the background.

Paramount Skydance Corp. (PSKY), Oracle Corp. (ORCL) and Tilray Brands (TLRY) each touched new 52-week lows on Monday as investors weighed merger uncertainty, artificial intelligence spending concerns and ongoing profitability challenges across three diff

Legal hurdle, AI spending and profit concerns weighed on sentiment.


Oracle Corp.

Warner Bros Discovery Inc

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.16	--	--	N/A
Q1 '26	-$0.18	-$0.32	-76.38%	MISSED
Q4 '25	-$0.01	-$0.43	-3471.43%	MISSED
Q3 '25	-$0.14	-$0.22	-64.79%	MISSED
Q2 '25	-$0.21	-$0.41	-91.89%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

TLRY Earnings

Latest Earnings Results: Q1 '26

Historical Earnings